低溫瓶市場：按容量、材料、無菌、最終用戶分類 - 2023-2030 年全球預測

全球低溫瓶市場預計將大幅成長，預計到 2023 年將達到 5.2516 億美元，年複合成長率為 5.24%，到 2030 年將達到 7.5219 億美元。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球低溫瓶市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 低溫瓶的全球市場規模與預測為何？

2.在預測期內，COVID-19 對全球低溫瓶市場的阻礙因素與影響有哪些？

3.在預測期內，全球低溫瓶市場需要投資哪些產品/細分市場/應用/領域？

4.全球低溫瓶市場的競爭策略為何？

5. 全球低溫瓶市場的技術趨勢和法律規範是什麼？

6.全球低溫瓶市場主要供應商的市佔率為何？

7. 哪些型態和策略措施被認為適合進入全球低溫瓶市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 生物製藥公司和合約研究組織的需求不斷增加
    • 生物樣本庫需求快速成長及生技產業成長
    • 改善新興經濟體的醫療保健服務
  • 抑制因素
    • 低溫瓶洩漏問題
  • 機會
    • 分發中的協作和線上使用開始
    • 支持產品可追溯性和可靠性的技術的顛覆
  • 任務
    • 處置問題
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化
  • 各地區的消費模式與趨勢

第6章 低溫瓶市場：依容量

• 容量1ml以下
• 容量：1ml至3ml
• 容量3ml~5ml
• 容量5ml以上

第7章 低溫瓶市場：依材料分類

• 聚乙烯
• 聚丙烯

第8章 低溫瓶市場無菌性別

• 伽瑪射線照射
• 非無菌
• 無菌的

第9章 低溫瓶市場：依最終用戶分類

• 製藥公司
• 醫院和診斷中心
• 研究機構

第10章 美洲低溫瓶市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第11章亞太低溫瓶市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第12章歐洲、中東和非洲低溫瓶市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第13章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第14章上市公司名單

第15章附錄

• 討論指南
• 關於許可證和定價

The Global Cryogenic Vials Market is forecasted to grow significantly, with a projected USD 525.16 million in 2023 at a CAGR of 5.24% and expected to reach a staggering USD 752.19 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cryogenic Vials Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cryogenic Vials Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Capacity, market is studied across Capacity 1 ml and Below, Capacity 1ml to 3 ml, Capacity 3 ml to 5 ml, and Capacity 5 ml and Above. The Capacity 3 ml to 5 ml is projected to witness significant market share during forecast period.

Based on Material, market is studied across Polyethylene and Polypropylene. The Polyethylene is projected to witness significant market share during forecast period.

Based on Sterility, market is studied across Gamma Irradiated, Non-Sterile, and Sterile. The Non-Sterile is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Drug Manufacturer, Hospital & Diagnostic Center, and Research Organization. The Hospital & Diagnostic Center is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cryogenic Vials Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cryogenic Vials Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cryogenic Vials Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cryogenic Vials Market?

4. What is the competitive strategic window for opportunities in the Global Cryogenic Vials Market?

5. What are the technology trends and regulatory frameworks in the Global Cryogenic Vials Market?

6. What is the market share of the leading vendors in the Global Cryogenic Vials Market?

7. What modes and strategic moves are considered suitable for entering the Global Cryogenic Vials Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Cryogenic Vials Market, by Capacity, 2022 vs 2030
• 4.3. Cryogenic Vials Market, by Material, 2022 vs 2030
• 4.4. Cryogenic Vials Market, by Sterility, 2022 vs 2030
• 4.5. Cryogenic Vials Market, by End-User, 2022 vs 2030
• 4.6. Cryogenic Vials Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand from bio-pharmaceutical companies and contract research organizations
    • 5.1.1.2. Surge in demand for bio-banking and growth in biotechnological industry
    • 5.1.1.3. Improving healthcare services in the developing economies
  • 5.1.2. Restraints
    • 5.1.2.1. Problems associated with leakage of Cryogenic vials
  • 5.1.3. Opportunities
    • 5.1.3.1. Collaboration in distribution and initiated online availability
    • 5.1.3.2. Technology interruptions supporting product traceability and authenticity
  • 5.1.4. Challenges
    • 5.1.4.1. Disposal Issue
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization
  • 5.9.1. Consumption Pattern & Trend by Geography

6. Cryogenic Vials Market, by Capacity

• 6.1. Introduction
• 6.2. Capacity 1 ml and Below
• 6.3. Capacity 1ml to 3 ml
• 6.4. Capacity 3 ml to 5 ml
• 6.5. Capacity 5 ml and Above

7. Cryogenic Vials Market, by Material

• 7.1. Introduction
• 7.2. Polyethylene
• 7.3. Polypropylene

8. Cryogenic Vials Market, by Sterility

• 8.1. Introduction
• 8.2. Gamma Irradiated
• 8.3. Non-Sterile
• 8.4. Sterile

9. Cryogenic Vials Market, by End-User

• 9.1. Introduction
• 9.2. Drug Manufacturer
• 9.3. Hospital & Diagnostic Center
• 9.4. Research Organization

10. Americas Cryogenic Vials Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cryogenic Vials Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cryogenic Vials Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. CRYOGENIC VIALS MARKET RESEARCH PROCESS
• FIGURE 2. CRYOGENIC VIALS MARKET SIZE, 2022 VS 2030
• FIGURE 3. CRYOGENIC VIALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2022 VS 2030 (%)
• FIGURE 5. CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2022 VS 2030 (%)
• FIGURE 6. CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2022 VS 2030 (%)
• FIGURE 7. CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 8. CRYOGENIC VIALS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. CRYOGENIC VIALS MARKET DYNAMICS
• FIGURE 10. CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. CRYOGENIC VIALS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. CRYOGENIC VIALS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. CRYOGENIC VIALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. CRYOGENIC VIALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 5. CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1 ML AND BELOW, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1ML TO 3 ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 3 ML TO 5 ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 5 ML AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 10. CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 13. CRYOGENIC VIALS MARKET SIZE, BY GAMMA IRRADIATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. CRYOGENIC VIALS MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. CRYOGENIC VIALS MARKET SIZE, BY DRUG MANUFACTURER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. CRYOGENIC VIALS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. CRYOGENIC VIALS MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 34. CANADA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 35. CANADA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 36. CANADA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. CHINA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 56. CHINA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 57. CHINA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 58. CHINA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. INDIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 60. INDIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 61. INDIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 62. INDIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. ITALY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 129. ITALY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 130. ITALY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 131. ITALY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. POLAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 145. POLAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 146. POLAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 147. POLAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. QATAR CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 149. QATAR CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 150. QATAR CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 151. QATAR CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. CRYOGENIC VIALS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 189. CRYOGENIC VIALS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 190. CRYOGENIC VIALS MARKET LICENSE & PRICING